GigaGen, Inc.

Industry

  • Biotechnology
    • Large Molecule
      • Antibodies
    • Drug Discovery Technologies
      • Bioinformatics
      • Genomics-Proteomics
  • Pharmaceuticals
See more in Biomedtracker

Latest on GigaGen, Inc.

Scrip

Finance Watch: Biopharma IPO Queue Grows As Market Conditions Improve

 
• By Mandy Jackson

The market for initial public offerings in the US heated up in September with five biopharmaceutical companies launching IPOs, the second busiest month for first-time offerings in 2024 after there wer

Scrip

Spain’s Grifols Takes Restructuring Route After COVID Challenges

 
• By Kevin Grogan

Grifols, S.A. is the latest biopharma company forced to cut its cloth to suit the straitened times the sector is suffering, with the Spanish plasma powerhouse unveiling plans to axe 8% of its workfor